Ratings by Truist Securities
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 10/20/2026 | Danielle Brill | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
56.00 (N/A) |
|
Details | |
| 10/20/2026 | Srikripa Devarakonda | Scholar Rock | SRRK | Maintain | Buy (N/A) |
77.00 (N/A) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 16,658 more... | |||||||||
